Table 4. Cumulative Incidence of Invasive Bladder Cancer After First Hospital-Based Hematuria Diagnosis.

Patient Characteristic	3 mo After Diagnosis, % (95% CI)	1 y After Diagnosis, % (95% CI)	5 y After Diagnosis, % (95% CI)
Total	1.98 (1.91-2.06)	2.26 (2.18-2.34)	2.64 (2.55-2.73)
Women	1.09 (1.00-1.18)	1.20 (1.11-1.30)	1.36 (1.26-1.46)
Men	2.55 (2.45-2.66)	2.93 (2.82-3.05)	3.31 (3.19-3.44)
Age group, y
0-29	0.01 (0.00-0.05)	0.01 (0.00-0.05)	0.01 (0.00-0.05)
30-49	0.24 (0.19-0.30)	0.26 (0.21-0.33)	0.31 (0.25- 0.38)
50-64	1.54 (1.42-1.67)	1.74 (1.61-1.87)	1.96 (1.82-2.11)
65-79	3.76 (3.57-3.96)	4.25 (4.05-4.47)	4.80 (4.58-5.03)
≥80	4.25 (3.93-4.58)	5.00 (4.66-5.36)	5.63 (5.26-6.01)
Inpatient	2.60 (2.43-2.77)	3.07 (2.89-3.25)	3.38 (3.19-3.57)
Outpatient	1.66 (1.58-1.75)	1.85 (1.76-1.94)	2.13 (2.03-2.23)
Emergency department patient	2.66 (2.35-2.99)	3.06 (2.73-3.42)	3.38 (3.03-3.76)
No previous urogenital disease	2.15 (2.06-2.24)	2.42 (2.32-2.51)	2.73 (2.63-2.83)
Previous urogenital disease	1.38 (1.25-1.52)	1.70 (1.56-1.85)	1.94 (1.78-2.10)
No comorbidity	1.66 (1.58-1.74)	1.87 (1.78-1.96)	2.12 (2.03-2.22)
Comorbidity present	2.71 (2.56-2.87)	3.14 (2.98-3.31)	3.53 (3.35-3.72)
Microscopic hematuria	1.88 (1.81-1.96)	2.16 (2.08-2.25)	2.46 (2.37-2.55)
Macroscopic hematuria	3.40 (3.04-3.79)	3.60 (3.22-4.00)	3.89 (3.49-4.33)